Clay Seagall’s Legacy with the Fight Against Cancer

Dr. Clay Siegall is the co-founder of Seattle Genetics which was established in 1998. He is also the Chief Executive Officer, the President, and the Chairman of the Board of Directors for this organization.

Seattle Genetics have been very successful in building a diversified pipeline of antibody based treatments for cancer. These milestones are achieved by Seattle Genetics entering various strategic licenses for their ADC technology. This includes AbbVie, Genentech (Roche), Pfizer, and GlaxoSmithKline. Through these licenses, over $325 million have been generated. And as a result, Seattle Genetics’ technology has been used in over 20 ADCs in clinical development across the different collaborator and internal program. Additionally, this company has also secured over $1.2 billion through various capital raising activities from private and public financings which also include the organization’s initial public offering in 2001. Through Dr. Siegall’s leadership, Seattle Genetics are making great strides for the betterment of mankind and society.

Before co-founding this amazing organization, Dr. Siegall acquired a plethora of executive leadership and medical experiences. He worked for the Bristol-Myers Squibb Pharmaceutical Research Institute prior to cofounding Seattle Genetics. From 1991 to 1997, he worked for the National Cancer Institute, and from 1988 to 1991, he worked for the National Institutes of Health. He also serves on different boards of directors, including Mirna Therapeutics, Ultragenyx Pharmaceutical, Washington Roundtable, and Alder BioPharmaceuticals.

And of course, Dr. Siegall’s medical experience began with his education. He has earned a Ph.D in Genetics from the George Washington University. He has also received a BS degree from the University of Maryland in Zoology.

And his accolades don’t stop there. In addition to acquiring various worthwhile accolades over the years, he has received a plethora of awards. One of his most deserved awards include the 2013 University of Maryland Alumnus of the Year for Computer, Math and Natural Sciences. Another award he achieved is the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year. And lastly, he has published over 70 publications, and he holds 15 patents.